While the new weight loss medications have been incredibly successful, their price tag has put them out of reach for many patients
The retrospective study identified 44,373 patients with IIH from the TriNetX US Collaborative Network who started GLP-1 RAs within 6 months of diagnosis (n = 603) and compared them with nonusers (n = 43,770) on various outcomes
And so yeah, my goal is always like, I want you to have that foundation of health
If you need to lose weight, JourneyLite can help!
(Shutter, 2019) Hematological: Pancytopenia, thrombocytopenia, neutropenia, folate-dependent megaloblastic anemia, aplastic anemia, pseudolymphoma, and actual lymphoma
Any of these signs mean the solution should be discarded